PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
29-Oct-2024 Dr. Falk Pharma Acquires Kynos Therapeutics, Adding Acute Pancreatitis as a Therapeutic Focus and Further Strengthening Its Development Portfolio Newswire
29-Oct-2024 Quantum Biopharma Announces that Sentinel Dosing has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in Australia Newswire
29-Oct-2024 SLS earns five Lab Awards nominations Scientific Laboratory Supplies
28-Oct-2024 Tanvex CDMO to Exhibit at the 15th Annual World ADC Conference in San Diego Newswire
28-Oct-2024 Ottimo Pharma Emerges from Stealth with Backing from Medicxi and Management Team Led by David Epstein to Accelerate Development of a Novel PD1/VEGFR2 Bi-Functional Antibody Planned to Enter the Clinic in 2025 Ottimo Pharma
28-Oct-2024 Aston Institute for Membrane Excellence holds business showcase with Arup and Bruntwood SciTech in Birmingham Tech Week Aston Institute for Membrane Excellence
28-Oct-2024 ONWARD® Medical Successfully Raises EUR 50 Million in an Upsized Capital Increase with Cornerstone Investment from Ottobock SE & Co. KGaA ONWARD Medical N.V.
28-Oct-2024 CluePoints Appoints Richard Young as Chief Strategy Officer CluePoints
28-Oct-2024 MIRA Pharmaceuticals' Ketamir-2 Shows 60% Greater Efficacy Than FDA-Approved Gabapentin in Reversing Chemotherapy-Induced Neuropathic Pain Newswire
24-Oct-2024 Belhaven Biopharma to Present Promising Phase 1 Data on Needle-Free Epinephrine Powder at ACAAI Annual Meeting Newswire
24-Oct-2024 MelliCell Awarded SEED Grant with Mass General Brigham to Propel Innovation in Diabetes and Obesity Newswire
24-Oct-2024 Körber and AspenTech partner to accelerate the digital transformation of clients using PAS-X MES and Aspentech Inmation Körber
23-Oct-2024 Lab supplier highlights sustainable practices at Lab Innovations Scientific Laboratory Supplies
23-Oct-2024 Ten businesses embark on Discovery Park’s ‘Discovery Spark’ programme Discovery Park
23-Oct-2024 Nitches, Inc. Unveils InTheZone Focused Extreme: A Premium Supplement for Enhanced Focus and Cognitive Performance Newswire
23-Oct-2024 ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement ProQR Therapeutics
23-Oct-2024 Angelini Pharma Enters Into An Exclusive Option Agreement With Cureverse to License Global Development and Commercialization Rights For A Novel and Innovative Clinical-Stage Brain Health Asset Angelini Pharma
23-Oct-2024 OKYO Pharma Announces First Patient Dosed in the First Clinical Trial to Treat Neuropathic Corneal Pain OKYO Pharma Limited
22-Oct-2024 Belhaven Biopharma’s Nasdepi® Named Finalist for 2024 Fierce Innovation Awards in Drug Delivery Technology Newswire
22-Oct-2024 Biocell Energetics – a new service to profile, in real-time, how cells produce energy University of Birmingham Enterprise